CoraLite® Plus 488 Anti-Mouse CD4 (RM4-5)
CD4 Monoclonal Antibody for IF/ICC, FC
Host / Isotype
Rat / IgG2a, kappa
Reactivity
Mouse and More (1)
Applications
IF/ICC, FC and More (1)
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
RM4-5
验证数据展示
经过测试的应用
Positive IF/ICC detected in | mouse splenocytes |
Positive FC detected in | mouse splenocytes |
推荐稀释比
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:250-1:1000 |
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
IF | See 2 publications below |
产品信息
CL488-65141 targets CD4 in IF/ICC, FC applications and shows reactivity with Mouse samples.
Tested Applications | IF/ICC, FC Application Description |
Cited Applications | IF |
Tested Reactivity | Mouse |
Cited Reactivity | mouse |
Immunogen | BALB/c mouse thymocytes 种属同源性预测 |
Host / Isotype | Rat / IgG2a, kappa |
Class | Monoclonal |
Type | Antibody |
Full Name | CD4 antigen |
Synonyms | Cd4, CD4 antigen, L3T4, Ly 4 |
GenBank Accession Number | BC039137 |
Gene Symbol | Cd4 |
Gene ID (NCBI) | 12504 |
RRID | AB_2883201 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.1% sodium azide and 0.5% BSA, pH 7.3. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 CD4 antibody CL488-65141 | Download protocol |
FC protocol for CL Plus 488 CD4 antibody CL488-65141 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Nat Commun In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis | ||
Cell Commun Signal Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma |